Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06938399 · ClinicalTrials.gov registry record · NA
Motiva Implants® Post-Approval Study
A NA study of Breast Implant, sponsored by Motiva USA.
- Recruiting
- Registry status
- NA
- Development phase
- 2,400
- Enrollment target
- 20
- Study locations
NCT06938399: Recruiting NA study of Breast Implant, sponsored by Motiva USA.
NCT06938399 is a NA study of Breast Implant that is actively recruiting participants, run by Motiva USA. The registered enrollment target is 2,400 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06938399, a NA study of Breast Implant, is actively recruiting participants, sponsored by Motiva USA.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,400 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study examines the general post-market use and safety of Motiva Implants® and gathers and assesses selected safety and effectiveness data about their post market performance and experience.
Primary Outcome
Analysis of Patient-Reported incidence of Connective Tissue Diseases (CTDs) and related systemic symptoms, collected through a questionnaire that includes the PROMIS-29 Survey
Conditions Studied
Interventions
- DEVICE Silicone gel-filled breast implants - Motiva Implants®
- OTHER Aesthetic Surgery
Study Locations (20)
California
- J. Gerald Minniti, M.D., F.A.C.S. - Beverly Hills
- AESTHETX Center - Camp Pendleton
- Align Surgical Associates Inc - San Francisco
- Schwartz Aesthetic Institute - Westlake Village
New Jersey
- Delaware Valley Plastic Surgery - Cherry Hill
- Caroline A. Glicksman MD - Sea Girt
New York
- Mark D. Epstein, MD, FACS Center for Aesthetic Surgery - Hauppauge
- Neinstein Plastic Surgery - New York
North Carolina
- HKB Cosmetic Surgery - Charlotte
- Capizzi, MD Cosmetic Surgery & Med Spa - Charlotte
Texas
- Restora Austin Plastic Surgery Center - Austin
- Austin Plastic Surgeon - Austin
Colorado
- The Center for Cosmetic Surgery - Denver
District of Columbia
- Advanced Plastic Surgery, LLC - Washington D.C.
Florida
- Careaga Plastic Surgery - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2037-07-31 |
| Phase | NA |
What NCT06938399 shows while recruiting
NCT06938399 is an interventional study that assigns participants to a tested intervention. Its 2,400 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% higher).
The record links to 1 condition, with Breast Implant appearing as the primary indexed condition, and to 2 interventions - of which Silicone gel-filled breast implants - Motiva Implants® is the first listed.
NCT06938399 names 20 study sites across 13 states, led by California, New Jersey, New York.
Frequently Asked Questions
What is clinical trial NCT06938399 about?
NCT06938399 is a clinical study titled "Motiva Implants® Post-Approval Study". This study examines the general post-market use and safety of Motiva Implants® and gathers and assesses selected safety and effectiveness data about their post market performance and experience.
What is the current status of trial NCT06938399?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,400 participants. The study started on 2025-05-01. Estimated completion is 2037-07-31.
What conditions does trial NCT06938399 study?
This clinical trial studies the following conditions: Breast Implant.
What interventions are being tested in trial NCT06938399?
The interventions under investigation include: Silicone gel-filled breast implants - Motiva Implants® (DEVICE), Aesthetic Surgery (OTHER).
Who is sponsoring clinical trial NCT06938399?
This trial is sponsored by Motiva USA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06938399 being conducted?
This trial has 20 study locations across California, Colorado, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Implant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06938399's enrollment target sits among peer trials
2,400 46th of 2000 higher than 1,955 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI